###begin article-title 0
###xml 77 90 77 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. Aeruginosa</italic>
Alveolar Epithelial Type II Cells Activate Alveolar Macrophages and Mitigate P. Aeruginosa Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: SK HG MW. Performed the experiments: SK HH DS AA. Analyzed the data: SK SL MW. Contributed reagents/materials/analysis tools: YC CH SL. Wrote the paper: SK MW.
###end p 1
###begin p 2
###xml 343 356 343 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 738 741 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 846 849 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1202 1205 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 343 356 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 1021 1025 <span type="species:ncbi:10090">mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
Although alveolar epithelial type II cells (AECII) perform substantial roles in the maintenance of alveolar integrity, the extent of their contributions to immune defense is poorly understood. Here, we demonstrate that AECII activates alveolar macrophages (AM) functions, such as phagocytosis using a conditioned medium from AECII infected by P. aeruginosa. AECII-derived chemokine MCP-1, a monocyte chemoattractant protein, was identified as a main factor in enhancing AM function. We proposed that the enhanced immune potency of AECII may play a critical role in alleviation of bacterial propagation and pneumonia. The ability of phagocytosis and superoxide release by AM was reduced by MCP-1 neutralizing antibodies. Furthermore, MCP-1-/- mice showed an increased bacterial burden under PAO1 and PAK infection vs. wt littermates. AM from MCP-1-/- mice also demonstrated less superoxide and impaired phagocytosis over the controls. In addition, AECII conditioned medium increased the host defense of airway in MCP-1-/- mice through the activation of AM function. Mechanistically, we found that Lyn mediated NFkappaB activation led to increased gene expression and secretion of MCP-1. Consequently Lyn-/- mice had reduced MCP-1 secretion and resulted in a decrease in superoxide and phagocytosis by AM. Collectively, our data indicate that AECII may serve as an immune booster for fighting bacterial infections, particularly in severe immunocompromised conditions.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Fehrenbach1">[1]</xref>
###xml 321 324 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Thorley1">[2]</xref>
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Sato1">[3]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Amano1">[4]</xref>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Lo1">[5]</xref>
###xml 545 548 545 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Restrepo1">[6]</xref>
###xml 872 894 872 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 1017 1030 1017 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1097 1100 1097 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Burns1">[7]</xref>
###xml 1102 1115 1102 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1444 1447 1444 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-LeVine1">[8]</xref>
###xml 1449 1452 1449 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Mariencheck1">[9]</xref>
###xml 872 894 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 1017 1030 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1070 1078 <span type="species:ncbi:9606">children</span>
###xml 1102 1115 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1200 1203 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Alveolar type II epithelial cells (AECII) maintain alveolar integrity by forming the alveolar barrier, producing surfactants and repairing injured type I epithelium [1]. Recently, several reports indicate that AECII may be an integral part of the lung innate immunity, acting to intensify the function of dendritic cells [2] and alveolar macrophages [3]. AECII may also perform other important functions such as cytokine secretion [4], antigen presentation [5] and enhancement of macrophage phagocytosis through surfactant proteins such as SP-D [6]. However, the role of AECII in infection immunity and underlying mechanism is largely unknown. Understanding the additional immunological role of AECII is important because professional immune cells such as alveolar macrophages (AM) in some cases rarely succeed in eradicating pathogens on their own. This is the case with Pseudomonas aeruginosa, an opportunistic gram-negative bacterium accounting for 10.1% of nosocomial infections. Clinical reports have shown that P. aeruginosa infects about 97.5% of Cystic Fibrosis children at age of 3 years [7]. P. aeruginosa infection is a main clinical problem in various immunodeficiency conditions such as HIV, severe burns, and cancers. This bacterium exhibits resistance to conventional antibiotics through a variety of virulence factors and there are no effective vaccines, making it difficult to eradicate once it colonizes the respiratory tract [8], [9].
###end p 4
###begin p 5
###xml 142 155 142 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Amano1">[4]</xref>
###xml 488 491 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Amano1">[4]</xref>
###xml 513 520 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Thorley2">[10]</xref>
###xml 868 881 868 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10116">rats</span>
###xml 142 155 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 673 678 <span type="species:ncbi:9606">human</span>
###xml 868 881 <span type="species:ncbi:287">P. aeruginosa</span>
Previous studies demonstrated that AECII cells can stimulate AM immunity in the lung of either mice or rats to boost the host defense against P. aeruginosa[4]. The caveats are that the studies have focused on whole animals to identify the cell types responsible for secreting chemokines by co-localization techniques. Also, the specific cell type involved in the immune activity has not been clearly defined. Although the main chemotactic factor released from AECII is likely to be MCP-1 [4], it is hard to prove in vivo whether AECII are the actual secreting cells. Also, the specific role of MCP-1 derived from AECII is less clear. A recent study suggested that isolated human AECII may secrete chemokines such as MCP-1 at higher amounts than AM primed with lipopolysaccharide (LPS) [10]. However, the specific immune response by characteristically defined AECII to P. aeruginosa infection remains to be determined. Furthermore, the underlying mechanism governing AECII mediated host immunity and regulatory factors involved in secretion of MCP-1 are not clearly established. Thus, it is necessary to investigate and fully establish the immune role of AECII.
###end p 5
###begin p 6
###xml 127 140 127 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 140 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
To determine the immunological function of AECII, we chose to investigate if AECII have a role in activating AM in response to P. aeruginosa infection. We used our primary cell culture models as well as mouse models including knockout mice to identify the signaling proteins that may regulate AM function and by identifying the cytokine products derived from AECII. We have shown here the importance of MCP-1 secreted by AECII in the activation of AM. Using MCP-1-/- mice, we also confirmed that MCP-1 has a crucial activity in increasing AM functionality through enhancing phagocytosis, increasing superoxide production, balancing inflammatory response and thereby optimizing host defense. In addition, we delineated the mechanism that regulates MCP-1 secretion in AECII, in which we found that Lyn, a critical Src family member, can increase MCP-1 secretion by activating the NF-kappaB pathway.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 300 313 300 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s001">Figure S1A, B</xref>
###xml 586 595 586 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g001">Figure 1A</xref>
###xml 612 621 612 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g001">Figure 1B</xref>
###xml 650 659 650 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g001">Figure 1C</xref>
###xml 841 847 841 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;0.05</italic>
###xml 859 860 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1021 1030 1021 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g001">Figure 1D</xref>
###xml 1130 1139 1130 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g001">Figure 1E</xref>
###xml 1255 1268 1255 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1523 1536 1523 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1770 1780 1770 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s001">Figure S1C</xref>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 1255 1268 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1523 1536 <span type="species:ncbi:287">P. aeruginosa</span>
Our objective was to test whether AECII in a culture system can boost the immune function of AM. Through co-culturing macrophages with lung epithelial cells, macrophages were significantly activated, demonstrating multiple functional activities including enhanced migration and actin reorganization (Figure S1A, B). To investigate whether secreted (soluble) substances are major mediators, we collected a conditioned medium from primary mouse AECII following PAO1 infection for 1 h and added to primary AM culture. After 24 h, AM activity was detected by three measurements: migration (Figure 1A), phagocytosis (Figure 1B) and superoxide production (Figure 1C). Our data indicates that the three AM function parameters were significantly increased by the AECII conditioned medium compared to the control medium from AECII without infection (P<0.05, Student's t test). The activated AM also showed more significant morphological changes with membrane projections such as lamellipodia and filopodia by confocal microscopy (Figure 1D). Moreover, we demonstrated apparent morphology alterations by scanning electron microscopy (SEM) (Figure 1E). Although we found that AECII have a role in activating AM, it is possible that AM themselves can be activated by P. aeruginosa, which enhances the function of resting AM through an autocrine loop. Thus, we evaluated whether the activated AM can bolster immunity by stimulating other naive AM. We co-incubated resting AM with a conditioned medium that was derived from AM following P. aeruginosa time course infection. As expected, we have found that the AECII conditioned medium indeed showed greater increases in AM migration and superoxide production compared to the AM-conditioned medium, particularly at earlier times (6 h, Figure S1C). However, AM also secreted comparable MCP-1 possibly through autocrine activation at 24 h.
###end p 8
###begin title 9
Conditioned medium from AECII by PAO1 infection activated AM (12 h).
###end title 9
###begin p 10
###xml 78 98 78 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 707 708 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) Increase of AM migration as determined by chemotaxic chamber methods (see Material and Methods). Migration index was calculated based on conditioned medium or control medium. (B) Increase in phagocytosis of AM as detected by CFU (colony forming units). (C) Increase in superoxide production of AM analyzed by H2DCF fluorescence (Molecular Probes). (D) The morphology of the activated AM is shown typically with lamllipodium and filopodium by confocal microscopy. (E) The morphology of the activated AM is further evidenced by high resolution and magnification Scanning Electron Microscopy (SEM). Statistical analysis was done by comparing mean individual values versus controls using student's t test, *p<0.05 (95% Confidence Interval, CI). The results are representative of three experiments.
###end p 10
###begin p 11
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 258 271 258 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 356 368 345 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2A, B</xref>
###xml 536 545 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2B</xref>
###xml 669 678 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2C</xref>
###xml 813 822 802 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2D</xref>
###xml 939 943 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Das1">[11]</xref>
###xml 945 955 934 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s002">Figure S2A</xref>
###xml 1026 1039 1015 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1053 1062 1042 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;in vivo&#8221;</italic>
###xml 1074 1078 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 1419 1428 1408 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2G</xref>
###xml 1541 1554 1530 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1566 1575 1555 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2E</xref>
###xml 1786 1799 1775 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1799 1803 1788 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 1856 1869 1845 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1894 1898 1883 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kowalski1">[13]</xref>
###xml 1899 1903 1888 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Zaas1">[15]</xref>
###xml 1905 1918 1894 1907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2131 2135 2120 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Hauser1">[16]</xref>
###xml 2235 2239 2224 2228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 2281 2294 2270 2283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2373 2386 2362 2375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2461 2474 2450 2463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2476 2485 2465 2474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2F</xref>
###xml 2623 2636 2612 2625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2701 2714 2690 2703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 2979 2992 2961 2974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 3114 3123 3096 3105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2G</xref>
###xml 3125 3132 3107 3114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004891-t001">Table 1</xref>
###xml 3137 3147 3119 3129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s002">Figure S2B</xref>
###xml 3225 3238 3207 3220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 3475 3484 3454 3463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g002">Figure 2G</xref>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
###xml 258 271 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 896 902 <span type="species:ncbi:10090">murine</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1026 1039 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
###xml 1500 1505 <span type="species:ncbi:9606">human</span>
###xml 1527 1535 <span type="species:ncbi:9606">patients</span>
###xml 1541 1554 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1650 1656 <span type="species:ncbi:9606">humans</span>
###xml 1786 1799 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1856 1869 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1905 1918 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2281 2294 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2373 2386 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2461 2474 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2623 2636 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2701 2714 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 2979 2992 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 3225 3238 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 3363 3368 <span type="species:ncbi:10090">mouse</span>
To investigate how AECII can activate AM, we studied the possible involvement of various cytokines and chemokines. Thus we performed an in vitro experiment with isolated primary mouse AECII to measure cytokines in the conditioned medium of AECII infected by P. aeruginosa, which showed a significant increase in MCP-1, IL-1beta, MIP-2alpha, and TNF-alpha (Figure 2A, B). We also showed that MCP-1 can transmit cellular signals to AM (4), and may be a dominant cytokine in cultured AECII cells. The secretion of MCP-1 is time dependent (Figure 2B). Also, we detected increased expression of MCP-1 and CCR2 (MCP-1 receptor) expression on AECII cells by western blotting (Figure 2C). We further confirmed that the MCP-1-secreting cells expressed SP-C (a marker of AECII) by co-localization with confocal microscopy (Figure 2D). Similar results showing cytokine secretion by AECII were also found in murine lung type II cell line MLE-12 cells [11] (Figure S2A). We then infected mice to investigate MCP-1 secretion in response to P. aeruginosa infection in "in vivo" conditions [12]. C57BL6 mice (8 weeks female, 5 mice per group) were infected with PAO1 intranasally, and broncho-alveolar lavage (BAL) was performed 18 h post infection. MCP-1 level was found to be increased as measured by immunohistochemistry in lung tissue, and PAO1 infected mice showed a significant increase in MCP-1 compared to uninfected controls (Figure 2G). Furthermore, the MCP-1 expression was demonstrated on AECII cells of human lung tissues from CF patients with P. aeruginosa infection (Figure 2E), suggesting that MCP-1 actually participated in host defense in infected humans. We showed that lipid rafts in AECII are reorganized into aggregates (platforms for cell signaling) following acute infection by P. aeruginosa[12], which is consistent with several studies regarding P. aeruginosa or other microorganisms [13]-[15]. P. aeruginosa has type three secretion system (T3SS) exoenzymes ExoS, ExoT, ExoU and ExoY, among which ExoS and ExoT are similar in the sequence and function for ADP ribosyltransferase and GTPase-activation protein activities [16]. The raft aggregates are differentially induced by various T3SS mutants or a pili deficient mutant [12]. Since there were some rafts outside the P. aeruginosa, we further quantified raft aggregates using Image J software and showed that P. aeruginosa infection induced strong raft aggregates, which were also associated with P. aeruginosa (Figure 2F). In addition, controls without infection did not show raft aggregates, thus the aggregates of lipid rafts may be a specific response to P. aeruginosa. Next, we used various inhibitors to define the raft pathway in P. aeruginosa adhesion and internalization into AECII. Among the various inhibitors we have tested, we found that the lipid raft inhibitor (mbetaCD), Lyn tyrosine kinase inhibitor (PP2), Akt inhibitor, and NF-kappaB inhibitor effectively blocked adhesion and internalization of P. aeruginosa, whereas the ceramide inhibitor (blocking sphingolipid pathway) only reduced internalization without affecting adhesion (Figure 2G, Table 1 and Figure S2B). This data suggests that ceramide and cholesterol may differentially impact P. aeruginosa adhesion and internalization. To further dissect the mechanism, we intranasally instilled cholesterol chelator mbetaCD into mouse lungs and found a reduction in bacterial internalization and MCP-1 secretion was also partially hindered (Figure 2G).
###end p 11
###begin title 12
MCP-1 from AECII was a major regulator by PAO1 infection.
###end title 12
###begin p 13
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 614 622 <span type="species:ncbi:9606">patients</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
(A) Increase of various proinflammatory factors at 24 h following stimulation with the conditioned medium from AECII infected by PAO1. (B) MCP-1 was significantly increased in a time dependent manner by the conditioned medium. (C) Both MCP-1 and its receptor of CCR2 were increased in AECII by PAO1 infection detected by western blotting. (D) Primary AECII secreted MCP-1 that was colocalized (arrows) with SP-C (a specific marker of AECII) as analyzed by immuno-fluorescence (anti-pro-SP-C from Dr. Jeffrey Whitsett). (E) Increase of MCP-1 expression in the AECII cells in human samples from Cystic Fibrosis (CF) patients (one of the 6 representative) stained by immunofluorescence. (F) Lipid raft quantification using Image J software. The colocalized pixels were identified and threshold defined vs. background. The image was converted into binary format and the "analyze particle tool" used to identify raft ranging in size of 15-255 pixels (correlates with 50-200 nm). (G) Blockade of lipid rafts with mbetaCD significantly reduced the secretion of MCP-1 in the lung vs. the control. The frozen sections for the lung tissue of C57BL6 mice (5 mice/group) were stained by anti-MCP-1 antibodies from Santa Cruz (arrows showing the positive staining). The results are representative of three experiments.
###end p 13
###begin title 14
Inhibition of adhesion and internalization of bacterium.
###end title 14
###begin p 15
Raft blockers (mbetaCD cholesterol chelator, and ceramide inhibitor [Racemic] 3 mM Alexis) hampered PA internalization. PP2 is Lyn inhibitor.
###end p 15
###begin p 16
###xml 130 139 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3A</xref>
###xml 380 389 380 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3B</xref>
###xml 617 626 617 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3C</xref>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3D</xref>
###xml 948 957 948 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3E</xref>
###xml 983 992 983 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g003">Figure 3F</xref>
###xml 1286 1299 1286 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s003">Figure S3A, B</xref>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
The expression of CCR2 (MCP-1 receptor) was increased in AM treated with AECII conditioned medium as determined by western blots (Figure 3A), indicating a functional involvement of this receptor in the pathway. Next, blocking of MCP-1 with neutralizing antibodies for 30 min before infection also down-regulated CCR2 compared to no antibody controls using fluorescent microscopy (Figure 3B). To further confirm the role of MCP-1, we added commercially available purified MCP-1 peptide (Calbiochem) directly to AM and found direct correlation between MCP-1 presence and AM activation, including superoxide production (Figure 3C). Furthermore, by blocking with MCP-1 neutralizing antibodies for 30 min before PAO1 infection, we observed that the mice showed more severe infection with increased bacterial burden (CFU/1 mg lung homogenates) compared to that in the wt mice (Figure 3D). In addition, the MCP-1 antibodies reduced superoxide production (Figure 3E) and phagocytosis by AM (Figure 3F) against the Ig isotype control. To ascertain the immune activity of AECII, we determined the immune symbolic markers, such as IL-12R and MHC Class II antigen by immunofluorescence. We showed that activated AECII expressed enhanced levels of MHC class II antigen as well as IL-12R and IL-17R (Figure S3A, B).
###end p 16
###begin title 17
MCP-1 receptor was increased along the enhanced immune function and MCP-1 antibody alleviated the infection.
###end title 17
###begin p 18
###xml 728 729 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
(A) The receptor of MCP-1 (CCR2/CKR2) was also increased in AECII by PAO1 infection detected with western blotting. (B) CCR2 expression following PAO1 infection was reduced by pre-incubating with MCP-1 antibodies (30 min) and determined by immunofluorescence. (C) Increase in superoxide release was measured using H2DCF by direct addition of the commercially available MCP-1 peptide. (D) BAL CFU from mice was increased by neutralizing antibodies against MCP-1 before PAO1 infection. (E) Superoxide was reduced in the AM from mice following instillation of MCP-1 antibodies as measured by NBT assay. (F) The AM from the same mice also demonstrated decreased phagocytosis ability. Statistical analysis was performed as above (** p<0.01, 99% CI). The results are representative of three experiments.
###end p 18
###begin p 19
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 184 197 184 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 297 310 297 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 397 406 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4A</xref>
###xml 483 492 483 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4B</xref>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 636 649 636 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 651 660 651 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4C</xref>
###xml 808 811 808 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 890 896 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E coli</italic>
###xml 908 917 908 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4D</xref>
###xml 1031 1038 1031 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1259 1268 1255 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4E</xref>
###xml 1626 1629 1622 1625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1708 1717 1704 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g004">Figure 4F</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 184 197 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 297 310 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 636 649 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 1630 1635 <span type="species:ncbi:10090">mouse</span>
To further determine the role of MCP-1 as an immune stimulator, MCP-1 deficient mice (MCP-/- mice) were used to study MCP-1 effects on AM immune function and physiological role during P. aeruginosa infection. This can also distinguish the relative contributions of MCP-1 to immune defense against P. aeruginosa infection. We found that MCP-1-/- mice showed increased bacterial burden in the lung (Figure 4A). A significant decrease in the superoxide production in AM was also noted (Figure 4B). Furthermore, the lung from MCP-1-/- mice showed increased lung cell death (showing decreased mitochondrial potential) following infection by P. aeruginosa (Figure 4C). Lung injury was also present as wet/dry ratio was increased by infection in the mice (data not shown). We also showed that isolated AM from MCP-1-/- mice after bacterial infection had increased ability to phagocytose opsonized-E coli particles (Figure 4D), indicating that the AM have not been saturated in uptaking bacteria (probably due to reduced migration) during in vivo infection. Interestingly, we noted that the lung injury is correlated with the increase in a number of pro-inflammatory factors such as MIP-2alpha (but probably also due to the loss of MCP-1) than the wild-type control (Figure 4E). Also, there was an increased neutrophil infiltration in the BAL (not shown). These data suggest that MCP-1 may be crucial in maintaining a fine balance between pro-inflammatory and anti-inflammatory cytokines, which is important for combating bacterial invasion as well as minimizing acute lung injury. Also, we instilled the conditioned medium into MCP-1-/- mouse lungs, which increased the host defense compared to the control medium (Figure 4F). These data critically confirm that MCP-1 is a potent immune regulator and inflammation controller in the airway spaces.
###end p 19
###begin title 20
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 55 68 <span type="species:ncbi:287">P. aeruginosa</span>
MCP-1-/- mice demonstrated functional involvement with P. aeruginosa infection.
###end title 20
###begin p 21
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 63 50 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 278 281 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 594 601 594 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 646 649 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 741 744 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 920 933 916 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 952 955 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 50 63 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 594 601 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 920 933 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
(A) MCP-1-/- mice showed more severe infection by P. aeruginosa (strains PAO1 and PAK) with an increase in bacterial burdens. Data were derived from a group of 5 infected and control mice (same in the figure). (B) Superoxide production was significantly altered in AM from MCP-1-/- mice following infection identified by NBT assay. (C) A significant increase in apoptotic cell death was observed in MCP-1-/- mice by bacterial infection. The data identified the loss of mitochondrial potential in MCP knockout mice, indicating increased cell apoptosis. (D) An increase opsonic phagocytosis with E. coli particles was found in AM derived from MCP-1-/- mice following infection. (E) An increase in inflammatory chemokine MIP-2alpha in the MCP-1-/- mice after PAO1 infection. The mRNA expression is shown in an agarose gel using semi-quantitative RT-PCR. (F) Conditioned medium partially restored the immune defense against P. aeruginosa infection in MCP-1-/- mice. Statistical analysis was as above. The results are representative of two experiments.
###end p 21
###begin p 22
###xml 506 518 482 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g005">Figure 5A, B</xref>
###xml 646 655 618 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g005">Figure 5C</xref>
###xml 745 754 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g005">Figure 5D</xref>
###xml 1073 1082 1041 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g005">Figure 5D</xref>
###xml 1115 1128 1083 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1629 1638 1591 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g005">Figure 5E</xref>
###xml 1115 1128 <span type="species:ncbi:287">P. aeruginosa</span>
Because raft signaling is partially dependent on T3SS, we attempted to define whether deletion in a single exoenzyme impacts the MCP-1 secretion by AECII. PAO1 wt and several toxin deficient strains (PAO1 DeltaExoS, DeltaExoT, PA14 DeltaExoU and DeltaExoY) were employed to examine the effect on AECII cells. Our data indicates that the various T3SS mutant strains influenced secretion of MCP-1 compared to PAO1 wt (except DeltaExoT), the highest inducer being DeltaExoS as determined by RT-PCR and ELISA (Figure 5A, B). Consequently, the conditioned medium from mutant strain DeltaExoS induced greater AM activation (phagocytosis) than PAO1 wt (Figure 5C). By contrast, DeltaExoS strain resulted in lesser superoxide in AM than PAO1 wt strain (Figure 5D). One possible explanation for this result is that loss of a particular exoenzyme may reduce the bacterial invasive ability, permitting the host to mount a better defense. The controls with normal medium, DMSO (for inhibitor dilution) and PAO1 supernatant induce measurable but lesser response than that of live PAO1 (Figure 5D). We next examined whether live P. aeruginosa is necessary to induce MCP-1 secretion by AECII and to turn the cells immunologically more potent. Using dead PAO1 (heating at 60degreesC for 1 h), supernatant, LPS and live PAO1 wt (in the same amount of bacteria and same number of cells), we compared differences in MCP-1 secretion during infection of AECII. We found that live PAO1 increased MCP-1 secretion more so than did dead PAO1, supernatants, and LPS. The conditioned medium from live infection also induced the strongest activation of AM (Figure 5E). Thus, it is likely that live bacterial infection initiated stronger stimulation of AECII secretion than dead bacterium or its components.
###end p 22
###begin title 23
Exoenzymes were involved in MCP-1 secretion.
###end title 23
###begin p 24
###xml 384 397 368 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 384 397 <span type="species:ncbi:287">P. aeruginosa</span>
(A) DeltaExoS strain induced increased MCP-1 mRNA and protein expression by MLE-12 lung epithelial cells assessed by RT-PCR and ELISA (B). (C) DeltaExoS strain resulted in increased phagocytosis by AM than PAO1 wt. (D) DeltaExoS strain induced decreased superoxide in AM (PAO1 sup: PAO1 supernatant; fMLP 5 microM from Sigma). (E) Less potency by dead PAO1, PAO1 supernatant and LPS (P. aeruginosa lipopolysaccharide, serotype 10, 200 ng/ml, Sigma) in inducing MCP-1 than live PAO1. (F) MCP-1 alone also induced MCP-1 secretion in primary AECII. Statistical analysis was performed as above. The results are representative of two experiments.
###end p 24
###begin p 25
###xml 242 255 242 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 347 360 347 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 591 601 591 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004891.s002">Figure S2B</xref>
###xml 242 255 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 347 360 <span type="species:ncbi:287">P. aeruginosa</span>
Since Src tyrosine kinase Lyn is located in the inner cytoplasm membrane of the cell, in the general proximity to lipid rafts, we investigated the role of several members of this family and discovered that Lyn (p53/56) played a major role in P. aeruginosa infection. We have demonstrated that Lyn was activated in A549 cells following exposure to P. aeruginosa[12]. Lyn phosphorylation was measured by immunoblotting with phosphor-Src antibodies on immunoprecipitated Lyn protein from cell lysates. Pre-treatment of AECII with 5 nM PP2 (synthetic inhibitor for Lyn) blocked MCP-1 secretion (Figure S2B).
###end p 25
###begin p 26
###xml 118 131 118 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
###xml 244 253 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g006">Figure 6A</xref>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 436 445 436 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g006">Figure 6B</xref>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 534 543 534 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g006">Figure 6C</xref>
###xml 741 754 737 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 902 906 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 1221 1230 1209 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g006">Figure 6D</xref>
###xml 1578 1587 1566 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g006">Figure 6E</xref>
###xml 118 131 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 741 754 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1517 1522 <span type="species:ncbi:9606">human</span>
###xml 1541 1549 <span type="species:ncbi:9606">patients</span>
To elaborate the role of Lyn in MCP-1 production, Lyn siRNA transfection was performed to assess the effect of Lyn on P. aeruginosa invasion (transfection efficiency >95%) [17], and our data show that MCP-1 was markedly decreased by Lyn siRNA (Figure 6A). Importantly, the role of Lyn was confirmed using Lyn-/- mice, demonstrating significantly reduced MCP-1 by PAO1 and PAK infection vs. Lyn wt mice as determined by mRNA expression (Figure 6B). Reduction of MCP-1 secretion was also observed in Lyn-/- mice as determined by ELISA (Figure 6C), whiles there is no difference between wt and KO mice in non-treated condition (data not shown). To probe downstream effectors in this pathway, we investigated NF-kappaB activation in response to P. aeruginosa infection. We evaluated this signaling process and our data showed that blocking of Lyn using dominant negative transfection of LynK275D construct [12] significantly reduced the NF-kappaB nuclear translocation compared to Lyn wt control transfectants (not shown). Using NF-kappaB luciferase plasmid, we found a pronounced increase in luciferase activity with conditioned medium obtained from PAO1 infected AECII cells, but this was blocked by LynK275D transfection (Figure 6D). We also observed similar Lyn-K275D-based inhibition in functional roles of AM. These findings suggest that Lyn signaling is linked to both the secretion of AECII and its functional role of AM. Finally, we also demonstrated that Lyn overexpression and increased phosphorylation in the human lung tissue of CF patients against the normal control (Figure 6E). Our data indicate that Lyn activation might have occurred during CF disease process, thus it is reasonable to propose that Lyn may serve as a therapeutic target for controlling the disease.
###end p 26
###begin title 27
Lyn regulated MCP-1 production by activating NF-kappaB.
###end title 27
###begin p 28
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 222 235 222 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 575 588 567 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 723 731 715 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 222 235 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 550 555 <span type="species:ncbi:9606">human</span>
###xml 575 588 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 611 619 <span type="species:ncbi:9606">patients</span>
(A) MCP-1 secretion was abolished by Lyn siRNA transfection in AECII cells. (B) Decrease in MCP-1 expression in the lungs. (C) Decrease in MCP-1 expression secretion in BAL fluid (bronchoalveolar lavage) in Lyn-/- mice by P. aeruginosa infection. Data were representative of two experiments with a group of 5 mice (infected and control). (D) Dominant negative Lyn construct transfection (DN = LynK275D) reduced NF-kappaB translocation in AECII as determined by a Luciferase NF-kappaB reporter assay. (E) Increased expression and activation of Lyn in human lung infected with P. aeruginosa. Tissues were from CF patients and normal controls (showing representative of 6 samples). Statistical analysis was done as above. The in vitro results are representative of three experiments.
###end p 28
###begin p 29
###xml 62 70 62 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g007">Figure 7</xref>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">which</italic>
The AECII - AM cross-talk is presented in a simplified model (Figure 7). Bacterial infection activates AECII cells that secrete chemokines (MCP-1). MCP-1 transmits signals to activate AM, which migrate towards infection sites and eliminate the pathogen. Lyn and lipid rafts may regulate MCP-1 and AM activation. In addition, the host defense may be balanced through the fine regulation by both Lyn and MCP-1.
###end p 29
###begin title 30
###xml 71 84 <span type="species:ncbi:287">P. aeruginosa</span>
Diagram delineates a pathway involved in the AECII immune role against P. aeruginosa infection.
###end title 30
###begin p 31
AECII cells initiate an immunity to boost AM anti-infection function. The chemokine MCP-1 seems a crucial factor in this cell-cell cross-talk, which may be initiated by lipid rafts and regulated by Lyn. While boosting MCP-1 production through NFkappaB pathway, Lyn may contain excessive production of MIP-2alpha as another mechanism to keep the inflammation response in control.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 183 196 183 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Thorley1">[2]</xref>
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Amano1">[4]</xref>
###xml 476 489 476 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 739 752 739 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1023 1036 1023 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1467 1480 1467 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1659 1672 1659 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 183 196 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 476 489 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 739 752 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1023 1036 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1122 1127 <span type="species:ncbi:10090">mouse</span>
###xml 1424 1428 <span type="species:ncbi:10090">mice</span>
###xml 1467 1480 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1659 1672 <span type="species:ncbi:287">P. aeruginosa</span>
Previous reports, either from animal studies or from work with lung epithelial cells, indicate that epithelial cells can secrete cytokines to increase AM immune function in combating P. aeruginosa infection [2], [4]. Our studies use both isolated AECII mouse cells and animals (including knockout mice) and demonstrate that the chemokine MCP-1 can up-regulate the innate immunity of AM. Innate immunity of the respiratory system in normal individuals is sufficient to prevent P. aeruginosa infection, but is unable to eradicate the bacteria in immunodeficient individuals, resulting in recurrent infection or acute dissemination. Activating the immunological functions of AECII may lend much-needed help in fighting microorganisms such as P. aeruginosa. The results from our studies demonstrate that MCP-1 production was dramatically increased after infection of AECII. Further, we have shown that direct application of synthetic MCP-1 peptide also boosts AM functions, albeit in a less potent way compared to induction by P. aeruginosa-infected medium. In addition, the instillation of MCP-1-neutralizing antibodies into mouse lungs blocks cytokine secretion and induces more severe pneumonia, indicating a critical functional role of this particular chemokine. The foremost function of these secreted factors is to recruit AM and boost their microbicidal activity. Importantly, we show direct evidence from MCP-1 knockout mice, which exhibited reduced clearance of P. aeruginosa and increased pathological alterations in the lungs. In contrast, reconstitution of MCP-1 using conditioned medium partially recovered the inadvertent pathophysiology induced by P. aeruginosa.
###end p 33
###begin p 34
###xml 294 307 294 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 364 377 364 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kowalski1">[13]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Zaas1">[15]</xref>
###xml 475 488 475 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 570 583 570 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Grassme1">[18]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Lafont1">[19]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
###xml 1013 1026 1013 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1318 1322 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kay1">[20]</xref>
###xml 1451 1455 1440 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Zhou1">[21]</xref>
###xml 294 307 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 364 377 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 475 488 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 570 583 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 648 651 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1013 1026 <span type="species:ncbi:287">P. aeruginosa</span>
Lipid microdomains of cell surface make the platforms and initiate dynamics that directly or indirectly regulate the down-stream activities, including cytokine secretion by AECII and bacterial phagocytosis by AM. We showed that lipid rafts in AECII are reorganized following acute infection by P. aeruginosa[12], which is consistent with several studies regarding P. aeruginosa or other microorganisms [13]-[15]. Thus we reasoned that AECII initial contact with the invading P. aeruginosa occurs through lipid rafts. Raft signaling may be beneficial to the host against P. aeruginosa[18], although some reports indicate that other pathogens (e.g., HIV) may use lipid rafts to subvert the innate immunity functions [19]. We also suggest that lipid rafts may directly associate the signaling pathway in activating AM [17]. Using ImageJ software, we provide quantitative evidence that lipid raft aggregates have a specific role in host defense against infection. Our data indicate that ceramide only associates with P. aeruginosa adhesion, while cholesterol impacts both adhesion and internalization to AECII cells. Our study also substantiates the role of lipid rafts in cytokine secretion, consistent with previous work in this field showing that TNF-alpha secretion is mediated by recruiting syntaxin-4 to lipid rafts [20]. Previous studies showed that various mechanisms such as JNK, TNF-alpha and IL1-beta are implicated in boosting MCP-1 secretion [21].
###end p 34
###begin p 35
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Subramanian1">[22]</xref>
###xml 600 604 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kowalski1">[13]</xref>
###xml 622 635 618 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 917 921 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Zhu1">[23]</xref>
###xml 922 926 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Hoyal1">[25]</xref>
###xml 622 635 <span type="species:ncbi:287">P. aeruginosa</span>
Importantly, we have identified that Lyn is crucial in host defense against bacterial infections. Lyn up-regulates MCP-1 secretion and promotes AM activity. Although Lyn was previously shown to be involved in the progression of Friend virus-induced erythroleukemia [22], Lyn's role in secretion of cytokines is not known. We also showed that the Lyn mediated regulation of MCP-1 secretion may be through the activation of NF-kappaB, which is a key transcriptional factor for inducing gene expression of many immune molecules including MCP-1. Our data are consistent with a report from Kowalski et al [13], who showed that P. aeruginosa infection of respiratory epithelial cells induced NF-kappaB nuclear translocation and blocking rafts using cholesterol chelating agents prevented this signaling. Lyn may also be able to increase reactive oxygen species production and release through the activation of PI3K and Akt [23]-[25] or other cellular signals (i.e., p47Phox, M.W., S.K., unpublished observations). Mechanistically, we identified a potential Lyn regulation site via H4 hyperacetylation at location K16 (unpublished). Additionally, we found that these responses may involve bacterial components including pili and ExoS. This is interesting because ExoS may be an important component of exoenzymes, responsible for intoxicating host defense mechanisms for bacterial benefit. In fact, pili as the surface structure of the bacterium may directly target lipid rafts to impact host signaling (not published). Also, reduction of MCP-1 production was seen when cells were challenged with a pili-deficient strain but increased MCP-1 secretion was noticed using the pili-corrected strain. Finally, our study also demonstrates that although dead bacteria or their partial products (LPS and supernatant) may have effects on igniting host defense, it is the live bacterium that stirred the strongest inflammatory response.
###end p 35
###begin p 36
###xml 45 58 45 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 191 204 191 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 832 840 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004891-g007">Figure 7</xref>
###xml 45 58 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 191 204 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
Whether or not AM are crucial for mitigating P. aeruginosa infection has been controversial. Our study has reaffirmed that AM are an important entity for exerting immune defense during acute P. aeruginosa infection. Our data indicates that activated AM are essential for phagocytosis of invading bacteria and scavenging dead bodies of neutrophils, evidenced by greater neutrophil penetration and pro-inflammatory cytokine response in Lyn-/- mice. The increased superoxide in AECII-activated AM can be utilized to kill the engulfed bacteria, particularly important during high doses of bacterial infection. Our results indicate that AM alone may be less effective, while cytokines or chemokines derived from AECII or other unidentified mechanisms may give AM an added power that is required for clearance of invading microorganisms (Figure 7). However, the effects of AECII immune roles may impact other cell types such as neutrophils and lymphocytes, which may be interesting directions for future studies.
###end p 36
###begin p 37
###xml 246 250 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-FitzerAttas1">[26]</xref>
###xml 414 418 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Neff1">[27]</xref>
###xml 419 423 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kamen1">[29]</xref>
###xml 780 793 776 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 802 806 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
###xml 808 821 804 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1023 1027 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Maresso1">[30]</xref>
###xml 1029 1042 1025 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 780 793 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 808 821 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1029 1042 <span type="species:ncbi:287">P. aeruginosa</span>
The Lyn axis maintains a fine balance involving several Src members or signaling proteins. Lyn through the ITAM motif up-regulates Syk function, which has been shown as important for opsonic phagocytosis by monocytes through FcgammaII mechanisms [26]. Lyn also has a positive role in ITIM motif that increases SH2 inositol phosphatase (SHIP), which may down-regulate inflammatory cytokines during acute infections [27]-[29]. Phagocytosis of the bacterium is dependent on many virulence factors as well as the host mediators. One of the major virulent effects of T3SS is disruption of cortical actin in phagocytic cells. We have reported earlier that a similar mechanism also exists in alveolar epithelium. Our recent study showed that T3SS is also involved in the phagocytosis of P. aeruginosa into AM [17]. P. aeruginosa releases these toxins directly into the host cytoplasm. Once activated, the ExoS and ExoT affect small GTPases by ADP ribosylation and GTPase activity, thereby deregulating cytoskeletal polymerization [30]. P. aeruginosa uses this mechanism to escape from phagocytosis and survive in the airways. Whether ExoS and ExoT have any direct effect on host cytokine secretion is less clear. Current studies demonstrate that secretion of MCP-1 may be inhibited by ExoS, as an ExoS-deficient strain induced even stronger secretion. Strain of DeltaExoS also reduced superoxide release, but by an unknown mechanism.
###end p 37
###begin p 38
###xml 143 156 143 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 598 611 598 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 143 156 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 598 611 <span type="species:ncbi:287">P. aeruginosa</span>
Together, our study not only delineates the immunological role of AECII but also suggests that AM, aided by AECII, are important for combating P. aeruginosa infection. Specifically, we identified that the secreted MCP-1 was a major booster for AM defense function and was regulated by Lyn. Furthermore, our data suggest that both Lyn and MCP-1 have crucial roles in balancing inflammatory response to bacterial challenge through interaction with various cell signaling proteins. The results from the current studies may open new avenues for the development of much-needed therapeutics for treating P. aeruginosa infection.
###end p 38
###begin title 39
Methods
###end title 39
###begin title 40

###end title 40
###begin title 41
Animals
###end title 41
###begin p 42
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Chan1">[31]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Hu1">[32]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Lu1">[33]</xref>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 551 564 551 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 783 796 783 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 551 564 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 783 796 <span type="species:ncbi:287">P. aeruginosa</span>
C57BL6 mice were purchased from the Jackson Laboratory. Lyn-/- mice based on J129/C57BL6 mice (6-8 weeks, female and male) were as described previously [31], [32]. MCP-1 mice were previously described [33], which were purchased from the Jackson Laboratory. The animal experiments have been approved by UND IACUC committee and were performed in accordance to the animal use and care guidelines. We anesthetized mice with 45 mg/kg ketamine plus 5 mg/kg diazepam, and intranasally instilled 0.1x107 (PAK) to 0.5x108 (PAO1) colony-forming units (CFUs) of P. aeruginosa for various times. After bronchoalveolar lavage (BAL), the trachea and lung were excised for homogenization or inflated with 50% OCT or formalin fixation. Intranasal instillation of the conditioned medium derived from P. aeruginosa infection with different bacterial strains was performed similarly as above. In selected experiments to check the efficiency of instillation, we used intratracheal instillation and ventilation procedures to confirm evenness of distribution in the lung.
###end p 42
###begin title 43
Cell culture
###end title 43
###begin p 44
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan1">[12]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Dobbs1">[34]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan3">[35]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Wu1">[36]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Wisniowski1">[37]</xref>
###xml 431 432 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 131 136 <span type="species:ncbi:10090">Mouse</span>
###xml 372 376 <span type="species:ncbi:9913">calf</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
Rat AECII cells were isolated as previously described and used within 2 days to preserve type II characteristics [12], [34], [35]. Mouse AM were isolated by bronchoalveolar lavage (BAL) concurrent to AECII isolation as described [17], [36], [37]. AECII cells were grown in Dulbecco's modified Eagle's medium (DMEM) and AM in RPMI 1640 medium supplemented with 10% newborn calf serum and penicillin/streptomicin antibiotics in 5% CO2 incubator. A549, MLE-12 and MHS cells were obtained from ATCC and maintained following the manufacture's instructions. For optimal seeding density, the cells were counted using neubauer chamber and dead cells were excluded by the trypan blue exclusion assay. We generated and collected conditioned medium from primary mouse AECII following PAO1 infection for 1 h and cultured another 24 h (after adding 100 microg/ml polymycin to kill the surface bacteria). The control medium without infection was collected for use. After co-culturing primary AM with the conditioned medium for 24 h, AM activity was detected by functional measurements as described in the related sections.
###end p 44
###begin title 45
Bacterial strains and infection
###end title 45
###begin p 46
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pilC</italic>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Stover1">[38]</xref>
###xml 122 131 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;fliC</italic>
###xml 156 159 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 167 170 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 181 184 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 230 239 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;pilC</italic>
###xml 326 330 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Preston1">[39]</xref>
###xml 346 349 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 357 360 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 368 371 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 382 385 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exo</italic>
###xml 447 451 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Miyata1">[40]</xref>
###xml 627 628 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
PAO1 wt is with an intact pilC gene and thus with twitching motility provided by Dr. S. Lory (Harvard) [38]. PAO1 wt GFP, DeltafliC (flagellin minus), DeltaexoS, DeltaexoT and DeltaexoU deletion mutant strains, PAK (pili wt), PAK DeltapilC (pili deficient) and PAO1 were obtained from Dr. Gerald Pier (Harvard Medical School) [39]. PA14 wt (DeltaexoS, DeltaexoT, DeltaexoU and DeltaexoY) were from Dr. E. Drenkard (Massachusetts General Hospital) [40] and used in selected experiments. Bacteria were grown overnight in LB medium at 37degreesC without shaking. Absorbance at 600 nm was measured for quantification (0.1 OD = 1x108 bacterium/ml).
###end p 46
###begin title 47
Immunohistochemistry and immunocytochemistry staining and confocal imaging
###end title 47
###begin p 48
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 399 404 <span type="species:ncbi:9606">human</span>
Adherent cells in Labtek chamber slides or animal/human tissue sections were stained for cell surface markers using appropriate primary antibodies and double stained for immunofluorescence with TRITC or FITC conjugated respective secondary antibodies. The cells were washed, and pictures taken with Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss MicroImaging, Inc, Thornwood, NY). The human samples were used in accordance to the NIH exempt guidelines and approved by the UND IRB committee. For live cell imaging, MatTek glass bottom dishes were used with a portable incubation chamber to keep cells at 37degreesC.
###end p 48
###begin title 49
RT-PCR analysis
###end title 49
###begin p 50
###xml 381 388 381 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004891-t002"><bold>Table 2</bold></xref>
###xml 265 268 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
RNA was extracted from Lung homogenates and cells with Trizol (Invitrogen Corporation) according to the manufacturer's instructions. For detected genes, reverse transcription (RT) was performed using 1.5 mg of RNA, RNase ribonuclease inhibitor, Oligo dT and cloned AMV reverse transcriptase (Invitrogen Corporation). cDNA was amplified using gene-specific primers as summarized in Table 2. PCR products were separated by 1.0% agarose gel electrophoresis containing ethidium bromide and visualized under UV light. The results for each gene were normalized in comparison with GAPDH expression.
###end p 50
###begin title 51
Primers for cytokines.
###end title 51
###begin title 52
Cytokine Immunoassay
###end title 52
###begin p 53
Cytokine concentrations were measured by ELISA kit (eBioscience company) in cell culture medium, BAL fluid and lung homogenates collected at indicated times after infection. Briefly, the cells were treated as described as above. On 24 h or 48 h, culture mediums were collected and cells. For BAL fluid, the trachea was surgically exposed and cannulated, lungs were lavaged 5 times with 1.0 ml volumes of lavage fluid, the lavageates were pooled, and cells were removed by centrifugation. For lung homogenates, excised lungs were ground using a sterile glass-Teflon(R) in 500 microl PBS. 96-well plates (Corning Costar 9018) were coated with 100 microl/well of capture antibody in coating buffer and incubated overnight at 4degreesC. 100 microl aliquots of serum samples were added to the coated microtiter wells. The cytokine concentrations were determined with corresponding detection HRP-conjugated antibodies. The values were read at 450 nm and analyzed.
###end p 53
###begin title 54
Western blot and Co-immunoprecipitation
###end title 54
###begin p 55
###xml 484 488 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Wu2">[41]</xref>
###xml 490 494 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Wu3">[42]</xref>
###xml 762 773 <span type="species:ncbi:3704">horseradish</span>
The sample from cells and lung homogenates were lysed and quantitated. The lysates were boiled for 5 min, and protease inhibitors added. The supernatants were collected, and 30 microg of each sample were loaded onto 10% SDS-polyacrylamide mini-gels and electrophoresed to resolve proteins. The proteins were then transferred to polyvinylidene difluoride membranes (Pierce Biotechnology) and blocked overnight at 4degreesC using 5% non-fat milk blocking buffer western antibody buffer [41], [42]. Membranes were incubated overnight at 4degreesC with the appropriate first antibodies diluted 1:1,000 in 5% non-fat milk blocking buffer. After washing three times with washing solution, the antigen-antibody complexes were incubated for 2 h at room temperature with horseradish peroxidase-conjugated secondary antibody (Amersham) diluted 1:2,000. Signals were visualized using enhanced chemiluminescence detection kit (SuperSignal West Pico; Pierce).
###end p 55
###begin p 56
For co-immuno-precipitation, the supernatants were pre-cleared with bare protein A/G-Sepharose beads (Pierce) for 1 h at 4degreesC and then incubated with anti-MCP-1, anti-NFkappaB, or anti-Lyn Abs (Santa Cruz) bound to protein A/G Sepharose beads overnight at 4degreesC. The next day, beads were washed three times in lysis buffer and boiled in SDS sample loading buffer. The proteins were separated and analyzed by western blotting.
###end p 56
###begin title 57
AM migration assay
###end title 57
###begin p 58
###xml 122 126 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-OBrien1">[43]</xref>
AM migration was evaluated in either 8 microm transwell cell culture insert or chemotaxis chamber as described previously [43] using Boyden chamber. Briefly, cells were plated on the upper chamber and allowed to adhere overnight. After treatment, the filter was washed in phosphate buffered saline (PBS) and turned upside down; the migrated cells in the bottom of the filter were counted using specific red fluorescence (DiI, Molecular probes) staining followed by confocal microscopy. Cells were visualized by exciting with 533 nm wavelength HeNe laser and emission detected in the red spectra with a long pass filter. At least 100 fields per sample were counted for statistical purpose.
###end p 58
###begin title 59
Fluorescent phagocytosis assay
###end title 59
###begin p 60
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 150 157 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
AM cells were plated in 96 well plates and grown overnight. The cells were treated with the conditioned medium from AEC II for 2 h. Then FITC labeled E. coli or GFP PAO1 was used to infect the cells at MOI 1:10. After 1 h incubation at 37degreesC the wells were washed and treated with Polymixin 100 microg/ml for 1 hr to kill any remaining extracellular bacteria. The number of phagocytosed bacteria was counted using Synergy HT fluorimeter (BioTek) with 485+/-20 nm excitation and 528+/-20 emission filters. Background correction was done for autofluorescence.
###end p 60
###begin title 61
Scanning electron microscopy (SEM)
###end title 61
###begin p 62
SEM was used to study morphology. AECII and AM cells were plated on collagen coated coverslips in 24-well plates. The cells were fixed in Karnovsky's fixative overnight, dehydrated by sequential alcohols, sputter coated with gold - palladium and images taken at 10000x magnification.
###end p 62
###begin title 63
Lung edema
###end title 63
###begin p 64
After infection, lungs were removed from the thoracic cavity, and the inferior third of the left lung were weighed and then placed in a drying oven at 90degreesC for 24 h. The specimen was reweighed, and the ratio of the weight before and after drying calculated.
###end p 64
###begin title 65
Lipid peroxidation assay
###end title 65
###begin p 66
Malondialdehyde (MDA) is an end product of lipid peroxidation process, and was measured in a colorimetric assay (Calbiochem, San Diego, CA) according to the manufacturer's instructions. Homogenized lung tissue in 62.5 mM Tris-HCL (pH = 6.8) supplemented with Complete-Mini Protease Inhibitor (Roche Diagnostics) in equal protein amounts were used in the assay.
###end p 66
###begin title 67
Lung myeloperoxidase (MPO) assay
###end title 67
###begin p 68
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Drannik1">[44]</xref>
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 305 306 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 328 329 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 331 332 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 357 358 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
MPO assay was performed as described [44]. Samples were homogenized in 50 mM hexadecyltrimethylammonium bromide (HTAB) 50 mM KH2PO4, pH 6.0, and 0.5 mM EDTA, 1 mL/100 mg tissue and centrifuged for 15 min at 12000 rpm at 4degreesC. Supernatants were decanted and 100 microl of reaction buffer (0.167 mg/mL O-dianisidine, 50 mM KH2PO4, pH 6.0 and 0.0005% mM H2O2) was added to 100 microl sample. Absorbance was read at 460 nm at 2 min intervals.
###end p 68
###begin title 69
H2DCF Assay for Superoxide production
###end title 69
###begin p 70
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Steinhauser1">[45]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
H2DCF dye (Molecular Probes) does not normally fluoresce and emits green fluorescence upon reaction with superoxide inside cells[45]. Cells were treated as above and equal amount(s) of dye added. Fluorescence was measured after 10 min incubation using the fluorimeter (BioTek, in our laboratory). For confirmation, NBT assay was used as we described previously [17].
###end p 70
###begin title 71
siRNA
###end title 71
###begin p 72
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004891-Kannan2">[17]</xref>
A pool of four specific siRNAs or sense controls was ('A pool' is singular) purchased from Dharmacon (West Lafayette, Colorado) to deplete Lyn in MLE-12, AECII and MSH cells and the depleted expression assessed as we previously described [17].
###end p 72
###begin title 73
Statistical analyses
###end title 73
###begin p 74
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Comparison of test with controls was done in triplicates and the results were analyzed using two tailed Student's t test with a P value<0.05. For multiple groups with an equal variance, we performed one-way ANOVA. For analyzing image data the sample size was increased by taking pictures of at least 100 cells per sample.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
AECII cells activate macrophages after PAO1 infection. Actin polymerization was induced by the medium from A549 cells infected by PAO1 in the Boyden chamber, which has two compartments separated by a porous membrane. RAW264 cells were seeded in the top and A549 cells in the bottom. Infection of A549 cells was done separately before inoculation into the chamber. Migrating cells were identified by staining the porous membrane with rhodamine phalloidin for actin and DAPI for nucleus and images taken by Zeiss confocal microscope. RAW264 cells started migrating towards infected A549 cells within 30 min (A). Quantification of actin cytoskeletal changes in RAW264 cells upon infection (B). RAW264 cells were grown on coverslips in 24 well plate. Cells were infected with PAO1 at 1:10 ratio for 1 h. The cells were fixed in 4% PFA and stained with FITC CT (Lipid raft marker) and Rhodamine Phalloidin (Actin). Untreated controls showed more number of cells (52%) with cytoskeletal changes like lamellipodium formation. The graph shows percent positive for cytoskeletal changes and error bar denotes standard deviation (P<0.01). AM conditioned medium has less potential for attracting AM than the conditioned medium from AECII by determining the migration index (C). Percentage of the migration of treated samples against total cells counted.
###end p 76
###begin p 77
(1.33 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
MCP-1 secreted by MLE-12 or isolated AECII is a major chemokine by PAO1 infection. MCP-1 expression is induced in MLE-12 cells by PAO1 infection. Lyn siRNA and various inhibitors (PP2 and Rac1 inhibitor, Calbiochem) decrease the expression of MCP-1 (A). AM under infection show less secretion of MCP-1 than AECII cells. Also, additional inhibitors examined demonstrate inhibition of MCP-1 expression in AM and AECII cells. In addition, co-culturing of AM with AECII induces increased secretion of MCP-1 than either cell alone (B).
###end p 79
###begin p 80
(1.16 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
Activated AECII demonstrate increased immunological characteristics including class II expression under PAO1 infection (A). Immunological markers including IL-12R (FITC) and IL-17R (TRITC) are increased against controls (not shown) under PAO1 infection (B) (all antibodies obtained from Santa Cruz).
###end p 82
###begin p 83
(1.59 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 506 511 <span type="species:ncbi:9606">human</span>
We would like to thank Drs. Gerald Pier, Stephen Lory, Joseph T Barbieri, and Eliana Drenkard for providing various PA strains and Dr. Thomas Smithgall for Lyn's constructs. We thank Dr. S. Pierce of NIAID for kindly providing us with the Lyn-YFP construct and Dr. O Miura of Tokyo Medical and Dental University for GST Lyn plasmids. We thank B. Grove, A. Eberhardt, S. Rolling, and D. Laturnus in UND imaging core for help with confocal and SEM imaging. We are indebted to Dr. Scott Randell for providing human tissue sections.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
Alveolar epithelial type II cell: defender of the alveolus revisited.
###end article-title 87
###begin article-title 88
###xml 8 13 <span type="species:ncbi:9606">human</span>
Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration.
###end article-title 88
###begin article-title 89
Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines.
###end article-title 89
###begin article-title 90
Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia.
###end article-title 90
###begin article-title 91
Alveolar epithelial type II cells induce T cell tolerance to specific antigen.
###end article-title 91
###begin article-title 92
###xml 48 70 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.
###end article-title 92
###begin article-title 93
###xml 27 49 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 59 67 <span type="species:ncbi:9606">children</span>
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
###end article-title 93
###begin article-title 94
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 55 77 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
###end article-title 94
###begin article-title 95
###xml 91 104 <span type="species:ncbi:287">P. aeruginosa</span>
Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa.
###end article-title 95
###begin article-title 96
###xml 109 114 <span type="species:ncbi:9606">human</span>
Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.
###end article-title 96
###begin article-title 97
Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression.
###end article-title 97
###begin article-title 98
###xml 30 52 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Src kinase Lyn is crucial for Pseudomonas aeruginosa internalization into lung cells.
###end article-title 98
###begin article-title 99
###xml 119 141 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation.
###end article-title 99
###begin article-title 100
TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells.
###end article-title 100
###begin article-title 101
Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2.
###end article-title 101
###begin article-title 102
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
###end article-title 102
###begin article-title 103
###xml 76 98 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Cholesterol-Rich Membrane Rafts and Lyn Are Involved in Phagocytosis during Pseudomonas aeruginosa Infection.
###end article-title 103
###begin article-title 104
###xml 21 43 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
###end article-title 104
###begin article-title 105
Bacterial subversion of lipid rafts.
###end article-title 105
###begin article-title 106
Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup.
###end article-title 106
###begin article-title 107
###xml 222 225 <span type="species:ncbi:10116">rat</span>
Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
###end article-title 107
###begin article-title 108
Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
###end article-title 108
###begin article-title 109
G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth.
###end article-title 109
###begin article-title 110
###xml 74 96 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization.
###end article-title 110
###begin article-title 111
Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase.
###end article-title 111
###begin article-title 112
Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn.
###end article-title 112
###begin article-title 113
Relationship of acute lung inflammatory injury to Fas/FasL system.
###end article-title 113
###begin article-title 114
The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.
###end article-title 114
###begin article-title 115
SHIP-1 increases early oxidative burst and regulates phagosome maturation in macrophages.
###end article-title 115
###begin article-title 116
###xml 80 102 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
###end article-title 116
###begin article-title 117
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.
###end article-title 117
###begin article-title 118
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
###end article-title 118
###begin article-title 119
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice.
###end article-title 119
###begin article-title 120
Isolation and culture of alveolar type II cells.
###end article-title 120
###begin article-title 121
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human 8-oxoguanine DNA glycosylase links MAPK activation to resistance to hyperoxia in lung epithelial cells.
###end article-title 121
###begin article-title 122
###xml 92 96 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice.
###end article-title 122
###begin article-title 123
Vitronectin protects alveolar macrophages from silica toxicity.
###end article-title 123
###begin article-title 124
###xml 28 55 <span type="species:ncbi:208964">Pseudomonas aeruginosa PA01</span>
Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen.
###end article-title 124
###begin article-title 125
###xml 55 77 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections.
###end article-title 125
###begin article-title 126
###xml 11 30 <span type="species:ncbi:7137">Galleria mellonella</span>
###xml 113 135 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
###end article-title 126
###begin article-title 127
Cell-specific delivery of bacteriophage-encapsidated ricin A chain.
###end article-title 127
###begin article-title 128
An improved Western blotting effectively reduces the background.
###end article-title 128
###begin article-title 129
Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells.
###end article-title 129
###begin article-title 130
###xml 62 84 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection.
###end article-title 130
###begin article-title 131
IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
###end article-title 131
###begin p 132
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 132
###begin p 133
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH ES014690 and P20 RR017699, American Heart Association Scientist Development Grant (National Office). The work is also supported by National Key Basic Research Program of China (973Program #2006CB504300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 133

